Jenscare Scientific Co., Ltd.

SEHK:9877 Stock Report

Market Cap: HK$2.2b

Jenscare Scientific Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:9877 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Apr 24SellHK$3,377,970Hangzhou Chende Investment Partnership Enterprise (L.P.)Company999,400HK$3.38
08 Apr 24SellHK$2,008,601CDBI PartnersCompany415,000HK$4.84
26 Jan 24BuyHK$539,200Fei PanIndividual40,000HK$13.48
25 Jan 24BuyHK$2,059,000Shiwen LvIndividual142,000HK$14.50
24 Jan 24BuyHK$1,082,640Shiwen LvIndividual78,000HK$13.88
22 Jan 24SellHK$16,009,999Ningbo Linfeng Biotechnology Co., LtdCompany1,000,000HK$16.01
19 Jan 24SellHK$12,800,002Ningbo Linfeng Biotechnology Co., LtdCompany800,000HK$16.00
04 Jan 24SellHK$4,564,045CDBI PartnersCompany255,600HK$17.86
04 Jan 24SellHK$2,705,317CD CapitalCompany151,600HK$17.85
12 Dec 23SellHK$18,719,999Ningbo Linfeng Biotechnology Co., LtdCompany1,200,000HK$15.60
24 Oct 23BuyHK$198,432Jiliu DuIndividual10,600HK$18.72

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 9877?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms25,366,6806.08%
Private Companies44,503,75210.7%
Institutions48,939,28111.7%
Employee Share Scheme78,377,73918.8%
Individual Insiders94,492,76022.7%
General Public125,487,07830.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 18 shareholders own 69.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.8%
Jenscare Scientific Co., Ltd., ESOP
78,377,739HK$413.1m23.1%no data
12.6%
Shiwen Lv
52,474,000HK$276.5m0.42%no data
9.44%
Jianhui Wu
39,368,160HK$207.5m-10.8%no data
6.36%
Hainan Maidi Enterprise Management L.P. (Limited Partnership)
26,520,141HK$139.8m-35.7%no data
6.21%
Ningbo Mukang Venture Capital Partnership (Limited Partnership)
25,890,840HK$136.4m0%no data
6.08%
CD Capital
25,366,680HK$133.7m1%no data
4.01%
Ningbo Linfeng Biotechnology Co., Ltd
16,708,600HK$88.1m-9.73%no data
2.23%
Zhuhai Hillhouse Equity Investment Management Co., Ltd.
9,309,060HK$49.1m-50%3.41%
2.18%
CDBI Partners
9,112,680HK$48.0m0%55.62%
0.88%
Primavera Capital Group
3,675,000HK$19.4m0%0.31%
0.62%
Hui Li
2,600,000HK$13.7m0%no data
0.46%
Duckling Fund, L.P.
1,904,312HK$10.0m0%no data
0.069%
Purekind Fund Management Co.,Ltd.
288,400HK$1.5m0%0.02%
0.0096%
Fei Pan
40,000HK$210.8k0%no data
0.0076%
Bosera Asset Management Co., Ltd.
31,800HK$167.5k0%no data
0.0025%
Jiliu Du
10,600HK$55.8k0%no data
0.00048%
Guotai Asset Management Company Limited
2,000HK$10.6k0%no data
0.00005%
E Fund Management Co., Ltd.
200HK$1.1k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.